The average Medicare Advantage star rating in 2025 is 3.92, a decline from 4.07 in 2024, marking the third consecutive year of lower ratings.
Between 2022 and 2025, the number of Medicare Advantage plans with a rating of 2 or 2.5 stars surged greatly, indicating a significant drop in quality.
In 2025, Part D out-of-pocket prescription drug costs will be capped at $2,000, but this change could have secondary effects on availability and coverage.
Collection
[
|
...
]